These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 9742990)
1. Tamoxifen prevention claim will not be allowed in USA. Ault A Lancet; 1998 Sep; 352(9131):883. PubMed ID: 9742990 [No Abstract] [Full Text] [Related]
2. [Tamoxifen in prophylaxis of breast cancer]. Bogush TA; Bogush EA Antibiot Khimioter; 2001; 46(1):30-4. PubMed ID: 11221083 [No Abstract] [Full Text] [Related]
3. Task force cautious about chemoprevention. Official guidelines are out about taking tamoxifen and raloxifene to prevent breast cancer. These drugs can help, but they aren't for everyone. Harv Womens Health Watch; 2002 Oct; 10(2):1-2. PubMed ID: 12393316 [No Abstract] [Full Text] [Related]
4. Re: Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 study. Narod S J Natl Cancer Inst; 1999 Jan; 91(2):188. PubMed ID: 9923863 [No Abstract] [Full Text] [Related]
5. Tamoxifen or raloxifene in postmenopausal women for prevention of breast cancer: a tale of two choices--counterpoint. Fabian C Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2210-2. PubMed ID: 18006909 [No Abstract] [Full Text] [Related]
6. Tamoxifen for breast cancer among hysterectomised women. Veronesi U; Maisonneuve P; Sacchini V; Rotmensz N; Boyle P; Lancet; 2002 Mar; 359(9312):1122-4. PubMed ID: 11943263 [TBL] [Abstract][Full Text] [Related]
7. Tamoxifen for the treatment and prevention of breast cancer: an update. Afflitto L Plast Surg Nurs; 2000; 20(4):234-6. PubMed ID: 12025059 [No Abstract] [Full Text] [Related]
8. Tamoxifen or raloxifene for breast cancer chemoprevention: a tale of two choices--point. Jordan VC Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2207-9. PubMed ID: 18006908 [No Abstract] [Full Text] [Related]
9. Tamoxifen reduces risk of breast cancer in high-risk women. Am J Health Syst Pharm; 1998 May; 55(10):978, 981. PubMed ID: 9606443 [No Abstract] [Full Text] [Related]
10. Third-generation SERMs may face uphill battle. Schmidt C J Natl Cancer Inst; 2010 Nov; 102(22):1690-2. PubMed ID: 21060064 [No Abstract] [Full Text] [Related]
11. Raloxifene prevails in STAR trial, may face easier road to acceptance than previous drugs. Vastag B J Natl Cancer Inst; 2006 Jun; 98(11):733-5. PubMed ID: 16757696 [No Abstract] [Full Text] [Related]
14. National Surgical Adjuvant Breast and Bowel Project breast cancer prevention trial: a reflective commentary. Fisher B J Clin Oncol; 1999 May; 17(5):1632-9. PubMed ID: 10334553 [No Abstract] [Full Text] [Related]
15. Tamoxifen hits the target in situ. Wilcken NR Lancet; 1999 Jun; 353(9169):1986-7. PubMed ID: 10376607 [No Abstract] [Full Text] [Related]
16. Tamoxifen: the herald of a new era of preventive therapeutics. Jordan VC J Natl Cancer Inst; 1997 Jun; 89(11):747-9. PubMed ID: 9182965 [No Abstract] [Full Text] [Related]
17. The Italian Tamoxifen Prevention Trial. Bonanni B; Veronesi U Dis Markers; 1999 Oct; 15(1-3):199-200. PubMed ID: 10644176 [No Abstract] [Full Text] [Related]
19. Aspirin may protect against breast cancer. But tamoxifen and mastectomy are still the only proven preventatives, though other approaches are under study. Health News; 2004 Sep; 10(9):6. PubMed ID: 15597442 [No Abstract] [Full Text] [Related]